NO20062279L - Farmasoytiske preparater - Google Patents

Farmasoytiske preparater

Info

Publication number
NO20062279L
NO20062279L NO20062279A NO20062279A NO20062279L NO 20062279 L NO20062279 L NO 20062279L NO 20062279 A NO20062279 A NO 20062279A NO 20062279 A NO20062279 A NO 20062279A NO 20062279 L NO20062279 L NO 20062279L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparations
dosing
aerosol suspension
formulation
suspension formulation
Prior art date
Application number
NO20062279A
Other languages
English (en)
Norwegian (no)
Inventor
Julianne Berry
Joel A Sequeira
Jill K Sherwood
Saeed Chaudhry
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20062279L publication Critical patent/NO20062279L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20062279A 2003-10-20 2006-05-19 Farmasoytiske preparater NO20062279L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51272503P 2003-10-20 2003-10-20
PCT/US2004/034359 WO2005041931A2 (fr) 2003-10-20 2004-10-18 Compositions pharmaceutiques

Publications (1)

Publication Number Publication Date
NO20062279L true NO20062279L (no) 2006-05-19

Family

ID=34549219

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062279A NO20062279L (no) 2003-10-20 2006-05-19 Farmasoytiske preparater

Country Status (13)

Country Link
US (2) US20050136009A1 (fr)
EP (1) EP1684717A2 (fr)
JP (2) JP2007509147A (fr)
KR (1) KR20060106823A (fr)
CN (1) CN1870976A (fr)
AU (1) AU2004285447A1 (fr)
BR (1) BRPI0415707A (fr)
CA (1) CA2542530A1 (fr)
MX (1) MXPA06004331A (fr)
NO (1) NO20062279L (fr)
SG (1) SG147453A1 (fr)
WO (1) WO2005041931A2 (fr)
ZA (1) ZA200603121B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4679901B2 (ja) * 2002-08-27 2011-05-11 シェーリング コーポレイション 定量吸入処方物を産生するためのプロセス
MXPA06008240A (es) * 2004-01-21 2006-08-31 Schering Corp Metodos de tratamiento.
AR059357A1 (es) * 2006-02-09 2008-03-26 Schering Corp Formulaciones farmaceuticas
BRPI0721256A2 (pt) * 2007-02-09 2013-03-12 Schering Corp aerossàis de fÁrmaco farmacÊuticos estÁveis
US20080253970A1 (en) * 2007-02-09 2008-10-16 Schering Corporation Stable Pharmaceutical Drug Products

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (fr) * 1956-03-21 1900-01-01
US2885427A (en) * 1956-11-15 1959-05-05 Dow Chemical Co Fluorination of trichloroethylene
US3320125A (en) * 1964-04-28 1967-05-16 Merck & Co Inc Inhalation aerosol composition
US3261748A (en) * 1964-07-17 1966-07-19 Dow Chemical Co 1,1,1,2-tetrafluoroethane anesthetic
GB1200886A (en) * 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
NL7708731A (nl) * 1976-08-13 1978-02-15 Montedison Spa Werkwijze voor de bereiding van nieuwe drijf- middelsamenstellingen voor aerosolen.
US4129603A (en) * 1978-02-07 1978-12-12 Imperial Chemical Industries Limited Manufacture of halogenated compounds
US4311863A (en) * 1980-06-11 1982-01-19 E. I. Du Pont De Nemours & Company Process for the manufacture of 1,1,1,2-tetrafluoroethane
US4851595A (en) * 1987-07-07 1989-07-25 E. I. Du Pont De Nemours And Company Liquid phase halogen exchange process for the manufacture of 1,1,1,2-tetrafluoroethane
US4967024A (en) * 1988-06-23 1990-10-30 E. I. Du Pont De Nemours And Company Catalyzed hydrofluorination process
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
DE4003270A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
US5118494A (en) * 1990-03-23 1992-06-02 Minnesota Mining And Manufacturing Company Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
US6006745A (en) * 1990-12-21 1999-12-28 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
ATE246497T1 (de) * 1991-06-10 2003-08-15 Schering Corp Fluorchlorkohlenwasserstoffreie aerosolformulierungen
EP0518601A1 (fr) * 1991-06-10 1992-12-16 Schering Corporation Formulations d'aérosols non-chlorofluorocarbonés
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
ATE204743T1 (de) * 1991-12-18 2001-09-15 Minnesota Mining & Mfg Aerosolzusammensetzungen für arzneimittelsuspensionen
US7101534B1 (en) * 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US7105152B1 (en) * 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
WO1993012161A1 (fr) * 1991-12-18 1993-06-24 Schering Corporation Procede destine a eliminer les additifs residuels d'articles en elastomere
US5202110A (en) * 1992-01-22 1993-04-13 Virginia Commonwealth University Formulations for delivery of beclomethasone diproprionate by metered dose inhalers containing no chlorofluorocarbon propellants
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
GB2314336A (en) * 1996-06-18 1997-12-24 Bespak Plc Method of cleaning or purifying elastomers and elastomeric articles which are intended for medical or pharmaceutical use
US6068832A (en) * 1996-08-29 2000-05-30 Schering Corporation Chlorofluorocarbon-free mometasone furoate aerosol formulations
KR100316358B1 (ko) * 1996-08-29 2001-12-12 둘락 노먼 씨. 클로로플루오로카본 비함유 모메타손 푸로에이트 에어로졸 제형
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
CA2417973A1 (fr) * 2000-08-04 2002-02-14 Longwood Pharmaceutical Research, Inc. Preparations de mometasone et bronchodilatateur pour administration par voie pulmonaire
EP1241113A1 (fr) * 2001-03-12 2002-09-18 CHIESI FARMACEUTICI S.p.A. Inhalateur avec des moyens pour améliorer la stabilité chimique des solutions d'aerosol médicinales qu'il contient
US20030148030A1 (en) * 2001-06-12 2003-08-07 Vernon Paul M. Barrier coatings for elastomeric materials
TWI324934B (en) * 2001-08-28 2010-05-21 Schering Corp Pharmaceutical compositions for the treatment of asthma
EP1461101A4 (fr) * 2001-12-07 2005-02-09 Glaxo Group Ltd Valve de dosage, son aerosol-doseur d'agent pharmaceutique et ses procedes
ES2281691T3 (es) * 2002-08-23 2007-10-01 Schering Corporation Composiciones farmaceuticas.
JP4679901B2 (ja) * 2002-08-27 2011-05-11 シェーリング コーポレイション 定量吸入処方物を産生するためのプロセス
US20080253970A1 (en) * 2007-02-09 2008-10-16 Schering Corporation Stable Pharmaceutical Drug Products

Also Published As

Publication number Publication date
EP1684717A2 (fr) 2006-08-02
SG147453A1 (en) 2008-11-28
ZA200603121B (en) 2007-09-26
KR20060106823A (ko) 2006-10-12
CA2542530A1 (fr) 2005-05-12
MXPA06004331A (es) 2006-06-05
WO2005041931A3 (fr) 2006-04-06
US20080064674A1 (en) 2008-03-13
US20050136009A1 (en) 2005-06-23
WO2005041931A2 (fr) 2005-05-12
JP2008024721A (ja) 2008-02-07
AU2004285447A1 (en) 2005-05-12
JP2007509147A (ja) 2007-04-12
BRPI0415707A (pt) 2006-12-19
CN1870976A (zh) 2006-11-29

Similar Documents

Publication Publication Date Title
CY1106549T1 (el) Φαρμακευτικες συνθεσεις που περιλαμβανουν κανναβη
WO2004066912A3 (fr) Compositions anti-inflammatoires et leurs utilisations
NO20054839L (no) Formulering for en oppmalt-dose inhalator ved anvendelse av hydro-fluor-alkaner som drivmidler
NO20062279L (no) Farmasoytiske preparater
ATE398999T1 (de) Aerosol-formulierungen von formoterol und mometason
WO2008020056A3 (fr) Formulation aérosol pour l'inhalation de bêta-agonistes
EA199900991A1 (ru) Медицинские аэрозольные препараты
NO20081582L (no) Benzamidforbindelser anvendbare som histon-deacetylaseinhibitorer
GB0323684D0 (en) Improvements in or relating to organic compounds
DE60123793D1 (de) Neue aerosolformulierungen ein polares fluoriniertes molekül enthaltend
AR057745A1 (es) Formulaciones de disoluciones de hfc que contienen hidrocloruro de salbutamol o citrato de salbutamol
MXPA04003105A (es) Nuevos metodos para inhibir la angiogenesis.
PE20011271A1 (es) Formulaciones que contienen una droga glucocorticoide para el tratamiento de enfermedades broncopulmonares
WO2011101114A3 (fr) Composition pharmaceutique inhalable
NO20083759L (no) Doserings aerosoler for administrering av farmasoytiske preparater
TNSN07289A1 (en) Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
JP2004529108A5 (fr)
NO20065722L (no) Medisinske aerosolformuleringsprodukter med forbedret kjemisk stabilitet.
NO20054495L (no) Nye anilinderivater, deres fremstilling og anvendelse som farmasoytiske forbindelser
HUP0004701A2 (hu) Új dezloratadin sók, az ezeket tartalmazó gyógyászati készítmények és eljárás azok előállítására
EA200900266A1 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ
EP1925293A3 (fr) Compositions d'aérosol pharmaceutique
BRPI0408003A (pt) produtos antiperspirante/desodorizante em aerossol
DE602004027629D1 (de) d-(17alpha)-13-ETHYL-17HYDROXY-18,19-DINORPREGN-4-ENE-20-YNE-3-ONE IN FORM DES REINEN 3E- UND 3Z-OXIMES SOWIE DAS VERFAHREN ZUR HERSTELLUNG DER MISCHU
WO2004103339A3 (fr) Inhalateur-doseur ameliore

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application